Síndrome de Laron: Reporte de caso

Abstract

Introduction and importance: Laron syndrome is a rare genetic condition that occurs very infrequently. This disease is treated with a single drug to improve the patient's quality of life, however, it can sometimes cause unusual side effects. Clinical case: A 9-year-old female patient diagnosed with Laron's Syndrome, confirmed by low levels of growth factor similar to insulin type 1 and normal or elevated levels of growth hormone. The same one that received temporary treatment with mecasermine. Clinical discussion: Treatment with mecasermin was started with a weight of 9.8 kg and a height of 89.2 cm. Seven months later, intracranial hypertension manifested itself, which is why the drug was suspended for three months, and later it was resumed at low doses. One year and ten months later, in his last control, a weight of 15.1 kg and a height of 97 cm were evidenced. Conclusion: Laron syndrome is a rare condition that is characterized by a marked short stature; currently, the only treatment to improve the development of height is the administration of mecasermin, which had beneficial results for the investigated patient.